מיוויו

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

TETROFOSMIN

Disponible desde:

ELDAN ELECTRONIC INSTRUMENTS CO LTD

Código ATC:

V09GA02

formulario farmacéutico:

אבקה מיובשת בהקפאה להכנת תמיסה להזרקה

Composición:

TETROFOSMIN 0.23 MG/VIAL

Vía de administración:

תוך-ורידי

tipo de receta:

מרשם נדרש

Fabricado por:

GE HEALTHCARE AS, NORWAY

Área terapéutica:

TECHNETIUM (99MTC) TETROFOSMIN

indicaciones terapéuticas:

Indicated as an adjunct in the diagnosis and localization of myocardial ischaemia or infarction. Myoview is indicated as an adjunct to the initial assessments (e.g. palpation mammography or alternative imaging modalities and/or cytology) in characterisation of malignancy of suspected breast lesions where all these other recommended tests were inconclusive.

Fecha de autorización:

2021-01-31